Harald F. Stock, PhD, Chief Executive Officer of Grünenthal GmbH - the German pharmaceutical company that developed thalidomide in the late 1950s - recently offered a public apology to those[…]
Harald F. Stock, PhD, Chief Executive Officer of Grünenthal GmbH - the German pharmaceutical company that developed thalidomide - recently offered a public apology to those who were harmed by[…]
Today’s Federal Register announces the permanent debarment by FDA of two individuals who worked for the Lee Research Institute in Lenexa, KS, in response to felony[…]
FDA and NIH could both face significant funding cuts if the executive branch is unable to reach an agreement with Congress on required spending cuts.[…]
Do you recognize any of these PIs? Dr. Studies, AKA Dr. “We Can Do That” Dr. Enrollment, AKA Dr. “I Want to Enroll an Incarcerated Schizophrenic Patient[…]
FDA recently issued a draft guidance addressing the issue of suicidal ideation and behavior that emerges during clinical trials of investigational drugs and biologics. The guidance[…]
FDA recently issued a draft guidance addressing the issue of suicidal ideation and behavior that emerges during clinical trials of investigational drugs and biologics. The guidance[…]
FDA and the Society of Clinical Research Associates (SoCRA) will co-sponsor a public workshop to be held November 14-15, 2012 in Baltimore, MD. The target[…]
FDA and the Society of Clinical Research Associates (SoCRA) will co-sponsor a public workshop to be held November 14-15, 2012 in Baltimore, MD. The target[…]
A panel of the US Circuit Court of Appeals for the District of Columbia determined late last week that federal funding of research involving human[…]